Aquaculture Vaccines Market Size to Hit USD 1,124.65 Mn By 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Aquaculture Vaccines Market

5.1. COVID-19 Landscape: Aquaculture Vaccines Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Aquaculture Vaccines Market, By Type of Vaccines

8.1. Aquaculture Vaccines Market Revenue and Volume Forecast, by Type of Vaccines

8.1.1. Inactivated Vaccines

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Live Vaccines

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Others

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Aquaculture Vaccines Market, By Route of Administration

9.1. Aquaculture Vaccines Market Revenue and Volume Forecast, by Route of Administration

9.1.1. Immersion Vaccines

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Injection Vaccines

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Oral Vaccines

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Aquaculture Vaccines Market, By Application

10.1. Aquaculture Vaccines Market Revenue and Volume Forecast, by Application

10.1.1. Bacterial Infection

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Viral Infection

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Aquaculture Vaccines Market, By Species

11.1. Aquaculture Vaccines Market Revenue and Volume Forecast, by Species

11.1.1. Salmon

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Trout

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Tilapia

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Aquaculture Vaccines Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.1.2. Market Revenue and Volume Forecast, by Route of Administration

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by Species

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.1.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by Species

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.1.6.2. Market Revenue and Volume Forecast, by Route of Administration

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by Species

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.2.2. Market Revenue and Volume Forecast, by Route of Administration

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by Species

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.2.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by Species

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.2.6.2. Market Revenue and Volume Forecast, by Route of Administration

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by Species

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.2.7.2. Market Revenue and Volume Forecast, by Route of Administration

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by Species

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.2.8.2. Market Revenue and Volume Forecast, by Route of Administration

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by Species

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.3.2. Market Revenue and Volume Forecast, by Route of Administration

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by Species

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.3.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by Species

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.3.6.2. Market Revenue and Volume Forecast, by Route of Administration

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by Species

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.3.7.2. Market Revenue and Volume Forecast, by Route of Administration

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by Species

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.3.8.2. Market Revenue and Volume Forecast, by Route of Administration

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by Species

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.4.2. Market Revenue and Volume Forecast, by Route of Administration

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by Species

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.4.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by Species

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.4.6.2. Market Revenue and Volume Forecast, by Route of Administration

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by Species

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.4.7.2. Market Revenue and Volume Forecast, by Route of Administration

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by Species

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.4.8.2. Market Revenue and Volume Forecast, by Route of Administration

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by Species

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by Species

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.5.5.2. Market Revenue and Volume Forecast, by Route of Administration

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by Species

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Type of Vaccines

12.5.6.2. Market Revenue and Volume Forecast, by Route of Administration

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by Species

Chapter 13. Company Profiles

13.1. Zoetis Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Phibro Animal Health Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Elanco

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck & Co., Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. KBNP

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Abbott

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Abbott

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Nisseiken Co., Ltd.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vaxxinova International BV

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. HIPRA

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The global aquaculture vaccines market size is expected to increase USD 1,124.65 million by 2035 from USD 553.40 million in 2025.

Answer : The global aquaculture vaccines market will register a growth rate of 8.27% between 2026 and 2035.

Answer : The major players operating in the aquaculture vaccines market are Zoetis Inc., Phibro Animal Health Corporation, Elanco, Merck & Co., Inc., KBNP, CAVAC, Kyoto Biken Laboratories, Inc., Nisseiken Co., Ltd., Vaxxinova International BV, HIPRA, Tecnovax, Virbac, Veterquimica S.A and Others.

Answer : The driving factors of the aquaculture vaccines market are the rising aquaculture businesses in developing countries and replicative antigen delivery system.

Answer : Europe region will lead the global aquaculture vaccines market during the forecast period 2026 to 2035.